S G Hilsenbeck Selected Research

Breast Neoplasms (Breast Cancer)

1/2019	A combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+ breast cancer.
1/2018	Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions.
11/2017	CYP2D6 genotype is not associated with survival in breast cancer patients treated with tamoxifen: results from a population-based study.
10/2011	Keratin 6a marks mammary bipotential progenitor cells that can give rise to a unique tumor model resembling human normal-like breast cancer.
8/2010	DNA repair signature is associated with anthracycline response in triple negative breast cancer patients.
11/2009	The efficacy of sertraline for controlling hot flashes in women with or at high risk of developing breast cancer.
7/2005	Hormone receptor status of a contralateral breast cancer is independent of the receptor status of the first primary in patients not receiving adjuvant tamoxifen.
6/2001	Pathological features and BRCA1 mutation screening in premenopausal breast cancer patients.
5/2001	AP-1 blockade inhibits the growth of normal and malignant breast cells.
3/2001	Hsp27-induced MMP-9 expression is influenced by the Src tyrosine protein kinase yes.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S G Hilsenbeck Research Topics

Disease

13	Breast Neoplasms (Breast Cancer) 01/2019 - 05/2000
11	Neoplasms (Cancer) 01/2019 - 05/2000
2	Carcinogenesis 01/2018 - 09/2000
1	Pathologic Complete Response 01/2019
1	Hyperprolactinemia 01/2018
1	Triple Negative Breast Neoplasms 08/2010
1	Hot Flashes 11/2009
1	Lung Neoplasms (Lung Cancer) 12/2000
1	Carcinoma (Carcinomatosis) 12/2000
1	Infections 05/2000
1	Fibrosis (Cirrhosis) 05/2000

Drug/Important Bio-Agent (IBA)

3	Estrogen ReceptorsIBA 01/2019 - 06/2001
3	Tamoxifen FDA LinkGeneric 11/2017 - 12/2000
3	DNA (Deoxyribonucleic Acid)IBA 11/2017 - 06/2001
2	Tumor Viral Antigens (Large T Antigen)IBA 10/2011 - 09/2000
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 05/2001 - 12/2000
2	Estrogens (Estrogen)FDA Link 12/2000 - 05/2000
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Trastuzumab (Herceptin)FDA Link 01/2019
1	Lapatinib (GW572016)FDA Link 01/2019
1	ProlactinIBA 01/2018
1	Aripiprazole (Abilify)FDA Link 01/2018
1	Janus Kinase 2IBA 01/2018
1	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2018
1	Antipsychotic Agents (Antipsychotics)IBA 01/2018
1	Pimozide (Orap)FDA Link 01/2018
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 11/2017
1	4-hydroxy-N-desmethyltamoxifenIBA 11/2017
1	Keratin-6 (Keratin 6A)IBA 10/2011
1	taxaneIBA 08/2010
1	AnthracyclinesIBA 08/2010
1	Sertraline (Zoloft)FDA LinkGeneric 11/2009
1	Hormones (Hormone)IBA 07/2005
1	ParaffinIBA 06/2001
1	Transcription Factors (Transcription Factor)IBA 05/2001
1	Doxycycline (Periostat)FDA LinkGeneric 05/2001
1	Complementary DNA (cDNA)IBA 03/2001
1	Small Heat-Shock ProteinsIBA 03/2001
1	EnzymesIBA 12/2000
1	Lipid PeroxidesIBA 12/2000
1	Glutathione (Reduced Glutathione)IBA 12/2000
1	Superoxide DismutaseIBA 12/2000
1	Glutathione Transferase (Glutathione S-Transferase)IBA 12/2000
1	AntioxidantsIBA 12/2000
1	Topotecan (Hycamtin)FDA LinkGeneric 12/2000
1	irofulvenIBA 12/2000
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2000
1	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 12/2000
1	Alitretinoin FDA Link 09/2000
1	RetinoidsIBA 09/2000
1	Progesterone Receptors (Progesterone Receptor)IBA 05/2000
1	Proteins (Proteins, Gene)FDA Link 05/2000
1	AlbuminsIBA 05/2000
1	Drinking WaterIBA 05/2000

Therapy/Procedure

4	Therapeutics 01/2019 - 07/2005
2	Drug Therapy (Chemotherapy) 01/2019 - 08/2010
1	Chemoprevention 01/2018
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 11/2009
1	Radiotherapy 05/2000
1	Mastectomy (Mammectomy) 05/2000
1	Length of Stay 05/2000
1	Laparoscopic Cholecystectomy 05/2000
1	Cholecystectomy 05/2000